Literature DB >> 10852789

Alterations in large and small proteoglycans in bleomycin-induced pulmonary fibrosis in rats.

N Venkatesan1, T Ebihara, P J Roughley, M S Ludwig.   

Abstract

In bleomycin (BM)-induced lung fibrosis, alterations have been shown in the expression and deposition of small proteoglycans (PGs). Less, however, is known about changes in large PGs. We investigated changes in large aggregating (versican [VS]), basement membrane (heparan sulfate proteoglycan [HSPG]), and small (biglycan and fibromodulin) PGs during the development of BM-induced pulmonary fibrosis. BM (1.5 U) was instilled intratracheally into male Sprague-Dawley rats. Control rats received saline. At 7, 14, and 28 d after administration of BM, lungs were excised; one lung was fixed in formalin and 5-microm sections were cut and stained with hematoxylin-eosin. The other lung was used for PG extraction. PGs were extracted with guanidine and were separated through composite gel polyacrylamide gel electrophoresis (PAGE) (large PGs) and sodium dodecylsulfate-PAGE (small PGs). Gels were either stained or electrophoretically transferred and probed with antibodies to VS, HSPG, biglycan, and fibromodulin. Histologic samples showed prominent inflammation, with abundant proteinaceous material, most evident in the samples obtained at 7 and 14 d after administration of BM. By 28 d after BM, much of the inflammatory response had resolved, and heterogeneous distribution of fibrosis was observed. Immunoblots showed a relative abundance of VS at 7 and 14 d. Control lungs stained minimally for VS. Levels of HSPG, biglycan, and fibromodulin were increased maximally at 14 d after administration of BM. Immunocytochemistry showed intense immunostaining of biglycan and fibromodulin in the areas of injured lung tissue from rats 14 and 28 d after BM administration. Control lungs revealed minimal staining for small PGs. Our findings indicate that changes in all subclasses of PGs occur during the development of BM-induced pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852789     DOI: 10.1164/ajrccm.161.6.9909098

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  25 in total

1.  Proteoglycan expression during transforming growth factor beta -induced keratocyte-myofibroblast transdifferentiation.

Authors:  J L Funderburgh; M L Funderburgh; M M Mann; L Corpuz; M R Roth
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

Review 2.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 3.  The role of proteoglycans in pulmonary edema development.

Authors:  Daniela Negrini; Alberto Passi; Andrea Moriondo
Journal:  Intensive Care Med       Date:  2008-02-09       Impact factor: 17.440

Review 4.  Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.

Authors:  Madalina V Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Biochim Biophys Acta       Date:  2014-02-05

Review 5.  You Say You Want a Resolution (of Fibrosis).

Authors:  Kamran Atabai; Christopher D Yang; Michael J Podolsky
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 6.  Heparan Sulfate in the Developing, Healthy, and Injured Lung.

Authors:  Sarah M Haeger; Yimu Yang; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2016-07       Impact factor: 6.914

7.  Quantification of collagen organization and extracellular matrix factors within the healing ligament.

Authors:  Connie S Chamberlain; Erin M Crowley; Hirohito Kobayashi; Kevin W Eliceiri; Ray Vanderby
Journal:  Microsc Microanal       Date:  2011-09-13       Impact factor: 4.127

8.  Localization of endothelin receptors in bleomycin-induced pulmonary fibrosis in the rat.

Authors:  Martina Wendel; Anna Petzold; Roland Koslowski; Michael Kasper; Antje Augstein; Lilla Knels; Jörg-Uwe Bleyl; Thea Koch
Journal:  Histochem Cell Biol       Date:  2004-10-05       Impact factor: 4.304

9.  Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis.

Authors:  James L Funderburgh; Mary M Mann; Martha L Funderburgh
Journal:  J Biol Chem       Date:  2003-08-20       Impact factor: 5.157

Review 10.  Matrix Remodeling in Pulmonary Fibrosis and Emphysema.

Authors:  Tejaswini Kulkarni; Philip O'Reilly; Veena B Antony; Amit Gaggar; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.